What's new? Log in Free sign up

Cosmos Health (COSM)

Company Profile

Company profile

Ticker

COSM

Exchange

Website

www.cosmosholdingsinc.com

CEO

Grigorios Siokas

Incorporated

Location

Fiscal year end

Industry (SIC)

Wholesale - Drugs, Proprietaries & Druggists' Sundries

McKesson • Cardinal Health • Cencora • Herbalife Nutrition • Nu Skin Enterprises • BIMI International Medical • Merion • Artemis Strategic Investment • Wellgistics Health • HWH International ...

Former names

Cosmos Holdings Inc., PRIME ESTATES & DEVELOPMENTS INC

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Cosmofarm Ltd. • SkyPharm, S.A. • Decahedron Ltd. • ZipDoctor Inc. • Cana Laboratories Holding (Cyprus) Limited ...

IRS number

270611758

COSM stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Results of Operations and Financial Condition

Quarterly report

14 Nov 25

Shelf registration

7 Nov 25

Regulation FD Disclosure

Departure of Directors or Certain Officers

Departure of Directors or Certain Officers

Additional proxy soliciting materials

Regulation FD Disclosure

Shelf registration (amended)

22 Sep 25

Prospectus supplement

Latest ownership filings

View all

Grigorios Siokas

Grigorios Siokas

Grigorios Siokas

Grigorios Siokas

Grigorios Siokas

Cosmos Health Inc.

Cosmos Health Inc.

Siokas Grigorios

Grigorios Siokas

Grigorios Siokas

Financial summary

Financial statements Chart COSM financial data

Quarter (USD)	Sep 25	Jun 25	Mar 25	Dec 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	4.63 mm	4.63 mm	4.63 mm	4.63 mm	4.63 mm	4.63 mm
Cash burn (monthly)	(no burn)	(no burn)	1.78 mm	1.55 mm	818.35 k	640.42 k
Cash used (since last report)	n/a	n/a	4.30 mm	3.73 mm	1.97 mm	1.54 mm
Cash remaining	n/a	n/a	329.18 k	903.01 k	2.66 mm	3.09 mm
Runway (months of cash)	n/a	n/a	0.2	0.6	3.2	4.8

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q4 2024

COSM institutional ownership history Ownership history

9.2% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1	7	-85.7%
Opened positions	1	5	-80.0%
Closed positions	7	0	NEW
Increased positions	0	1	EXIT
Reduced positions	0	1	EXIT

13F shares	Current	Prev Q	Change
Total value	1.66 mm	508.18 mm	-99.7%
Total shares	2.51 mm	581.03 k	+331.6%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Armistice Capital	2.51 mm	$1.66 mm	NEW

Largest transactions	Shares	Bought/sold	Change
Armistice Capital	2.51 mm	+2.51 mm	NEW
BlackRock	0.00	-267.80 k	EXIT
Geode Capital Management	0.00	-149.73 k	EXIT
Vanguard	0.00	-134.83 k	EXIT
NTRS Northern Trust	0.00	-20.55 k	EXIT
NA.R National Bank of Canada	0.00	-7.00 k	EXIT
Simplex Trading	0.00	-919.00	EXIT
Cornerstone Planning	0.00	-200.00	EXIT
FMR	0.00	0.00
Proequities	0.00	0.00

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

COSM insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
28 Nov 25	Siokas Grigorios	Common Stock, par value $.001	Buy	Acquire P	No	No	0.6417	76,360	49.00 k	6,459,985
25 Nov 25	Siokas Grigorios	Common Stock, par value $.001	Buy	Acquire P	No	No	0.628	55,732	35.00 k	6,383,625
21 Nov 25	Siokas Grigorios	Common Stock, par value $.001	Buy	Acquire P	No	No	0.6776	56,080	38.00 k	6,327,893
20 Nov 25	Siokas Grigorios	Common Stock, par value $.001	Buy	Acquire P	No	No	0.6236	51,315	32.00 k	6,271,813
19 Nov 25	Siokas Grigorios	Common Stock, par value $.001	Buy	Acquire P	No	No	0.6492	61,614	40.00 k	6,220,498

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Cosmos Health Announces Long‑Term Strategic Partnership With Prime Ledger To Digitally Transform $300M Treasury And Tokenize IP

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced a long-term strategic partnership with Prime Ledger LLC ("Prime Ledger"),

Cosmos Health Q3 Adj. EPS $(0.02) Up From $(0.34) YoY, Sales $17.110M Up From $12.411M YoY

Cosmos Health (NASDAQ:COSM) reported quarterly losses of $(0.02) per share. This is a 94.12 percent increase over losses of $(0.34) per share from the same period last year. The company reported $17.110 million in sales

Cosmos Health Acquires An Additional $200K Worth Of Ethereum, Bringing The Company's Total Investment In ETH To $2M

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has acquired an additional $200,000 worth of Ethereum (ETH),

Cosmos Health Purchases Additional $300K Worth Of Ethereum, Increasing Total Investment In ETH To $1.8M

Cosmos Health Buys Additional $500K Worth Of Ethereum

Press releases

From Benzinga Pro

Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets

CHICAGO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced a long-term

Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases

CHICAGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that Chief Executive

Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M

CHICAGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today reported financial results for

Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy

Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.